HRP20120605T1 - Postupci sinteze 9-supstituiranog minociklina - Google Patents

Postupci sinteze 9-supstituiranog minociklina Download PDF

Info

Publication number
HRP20120605T1
HRP20120605T1 HRP20120605AT HRP20120605T HRP20120605T1 HR P20120605 T1 HRP20120605 T1 HR P20120605T1 HR P20120605A T HRP20120605A T HR P20120605AT HR P20120605 T HRP20120605 T HR P20120605T HR P20120605 T1 HRP20120605 T1 HR P20120605T1
Authority
HR
Croatia
Prior art keywords
minocycline
conditions
substituted
substituted minocycline
compound
Prior art date
Application number
HRP20120605AT
Other languages
English (en)
Croatian (hr)
Inventor
Seyedi Farzaneh
Warchol Tadeusz
Grier Mark
Original Assignee
Paratek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharmaceuticals filed Critical Paratek Pharmaceuticals
Publication of HRP20120605T1 publication Critical patent/HRP20120605T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
HRP20120605AT 2007-07-06 2012-07-23 Postupci sinteze 9-supstituiranog minociklina HRP20120605T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94838507P 2007-07-06 2007-07-06
US6035108P 2008-06-10 2008-06-10
PCT/US2008/008355 WO2009009042A1 (en) 2007-07-06 2008-07-07 Methods for synthesizing substituted tetracycline compounds

Publications (1)

Publication Number Publication Date
HRP20120605T1 true HRP20120605T1 (hr) 2012-09-30

Family

ID=39926392

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120605AT HRP20120605T1 (hr) 2007-07-06 2012-07-23 Postupci sinteze 9-supstituiranog minociklina

Country Status (18)

Country Link
US (2) US9522872B2 (de)
EP (2) EP2192111A3 (de)
JP (2) JP2010532759A (de)
KR (1) KR20100042276A (de)
CN (2) CN101784517A (de)
AT (1) ATE555079T1 (de)
AU (2) AU2008275701B2 (de)
BR (2) BRPI0823405A2 (de)
CA (1) CA2693376A1 (de)
DK (1) DK2176216T3 (de)
EA (2) EA201070233A1 (de)
ES (1) ES2386926T3 (de)
HK (1) HK1139386A1 (de)
HR (1) HRP20120605T1 (de)
IL (1) IL204133A0 (de)
PT (1) PT2176216E (de)
WO (1) WO2009009042A1 (de)
ZA (2) ZA201000034B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
CA2531728A1 (en) * 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2295419A3 (de) * 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclinverbindungen
JP2008530023A (ja) 2005-02-04 2008-08-07 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の11a,12−誘導体
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
EP2026776A2 (de) * 2006-05-15 2009-02-25 Paratek Pharmaceuticals, Inc. Verfahren zur regelung der genexpression oder genprodukte mithilfe von substituierten tetracyclinverbindungen
IL270446B2 (en) * 2006-12-21 2023-10-01 Paratek Pharm Innc A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
EP3488853A1 (de) 2006-12-21 2019-05-29 Paratek Pharmaceuticals, Inc. Substituierte tetracyclinverbindungen zur behandlung von entzündlichen hauterkrankungen
AU2008239606A1 (en) 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
CA2717703A1 (en) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
US20100022483A1 (en) * 2008-04-14 2010-01-28 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
EA201170425A1 (ru) * 2008-09-19 2011-10-31 Паратек Фармасьютикалс, Инк. Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
IN2012DN02502A (de) * 2009-08-28 2015-08-28 Tetraphase Pharmaceuticals Inc
WO2012065028A2 (en) 2010-11-11 2012-05-18 Concert Pharmaceuticals Inc. Substituted tetracyclines
SG10201801703RA (en) 2012-08-31 2018-04-27 Tetraphase Pharmaceuticals Inc Tetracycline compounds
MA46567A (fr) 2016-10-19 2019-08-28 Tetraphase Pharmaceuticals Inc Formes cristallines de l'éravacycline
WO2018085216A1 (en) 2016-11-01 2018-05-11 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquire bacterial pneumonia (cabp)
WO2019192614A1 (en) * 2018-04-06 2019-10-10 Paratek Pharmaceuticals, Inc. Process for making sarecycline hydrochloride
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2820824A (en) 1957-04-15 1958-01-21 American Cyanamid Co Purification of neutral tetracycline
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
US3304227A (en) 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
NL6607516A (de) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3876699A (en) 1969-10-01 1975-04-08 Squibb & Sons Inc Purification of tetracycline antibiotic
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4704383A (en) 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
USRE34656E (en) 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
US4935412A (en) 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US5308839A (en) 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
JP3016587B2 (ja) 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5770588A (en) 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
US6756365B2 (en) 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
US5258371A (en) 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US6043225A (en) 1992-06-12 2000-03-28 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
DK0599397T3 (da) 1992-11-17 1996-09-16 Univ New York State Res Found Tetracycliner, herunder non-mikrobielle, kemisk-modificerede tetracycliner, inhiberer overdreven collagentværbinding ved diabetes
US5523297A (en) 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US6043231A (en) 1993-03-02 2000-03-28 The Research Foundation Of State Univ. Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5668122A (en) 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
AU1279095A (en) 1994-02-17 1995-09-04 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5843925A (en) 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
JPH09227439A (ja) * 1996-02-22 1997-09-02 Teikoku Chem Ind Corp Ltd アルデヒド化方法
US5834449A (en) 1996-06-13 1998-11-10 The Research Foundation Of State University Of New York Treatment of aortic and vascular aneurysms with tetracycline compounds
US5827840A (en) 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5919774A (en) 1996-12-10 1999-07-06 Eli Lilly And Company Pyrroles as sPLA2 inhibitors
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5773430A (en) 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US5929055A (en) 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
WO1999037307A1 (en) 1998-01-23 1999-07-29 Trustees Of Tufts College Pharmaceutically active compounds and methods of use thereof
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6015804A (en) 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5977091A (en) 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury
US5998390A (en) 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US8106225B2 (en) 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
CA2383364C (en) * 1999-09-14 2009-11-17 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6231894B1 (en) 1999-10-21 2001-05-15 Duke University Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
EP1250332A1 (de) * 1999-12-17 2002-10-23 Abbott Laboratories Inhibitoren des interleukin-5 genausdrucks
AU3105801A (en) 2000-01-24 2001-07-31 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
DE60129116T2 (de) 2000-03-31 2008-03-13 Trustees Of Tufts College, Medford 7- und 9-carbamat, harnstoff, thioharnstoff, thiocarbamat und heteroaryl-amino substituierte tetracyclinverbindungen
EP1286954B1 (de) 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituierte kondensierte ring-tetrazyclin- verbindungen
AU2001268475A1 (en) 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20050143353A1 (en) 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
EP2289871A1 (de) 2000-07-07 2011-03-02 Paratek Pharmaceuticals, Inc. 7-substituierte tetracyclinverbindungen
AU2001271556A1 (en) 2000-07-07 2002-01-21 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
AU8638801A (en) 2000-07-07 2002-01-21 Tufts College 9-substituted minocycline compounds
EP1241160A1 (de) 2001-03-13 2002-09-18 Glaxo Group Limited Tetracyclinderivate und ihre Verwendung als Antibiotica
AU2002250331A1 (en) 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP2301914A1 (de) 2001-03-13 2011-03-30 Paratek Pharmaceuticals, Inc. 7, 9-substituierte Tetracyclin-Verbindungen
WO2003055441A2 (en) 2001-08-02 2003-07-10 Paratek Pharmaceuticals, Inc. Medicaments
US6908939B2 (en) * 2001-12-21 2005-06-21 Galderma Research & Development S.N.C. Biaromatic ligand activators of PPARγ receptors
JP2003252803A (ja) * 2002-03-01 2003-09-10 Sumitomo Chem Co Ltd 置換不飽和化合物の製造法
EP2316450A1 (de) 2002-03-08 2011-05-04 Paratek Pharmaceuticals, Inc. Aminomethyl-substituierte Tetracyclin-Verbindungen
AU2003218243B2 (en) * 2002-03-21 2010-04-01 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2492273C (en) 2002-07-12 2013-02-05 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
US6846938B2 (en) * 2002-07-29 2005-01-25 Eastman Kodak Company Water-compatible epoxy compounds containing sulfonate or thiosulfate moieties
WO2004091513A2 (en) 2003-04-10 2004-10-28 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP2292590A3 (de) * 2003-07-09 2012-05-02 Paratek Pharmaceuticals, Inc. Prodrugs aus 9-Aminomethyl-Tetracyclinverbindungen
CA2531728A1 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20060287283A1 (en) 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP5010284B2 (ja) 2004-01-15 2012-08-29 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の芳香族a環誘導体
WO2005075439A1 (en) 2004-02-03 2005-08-18 Astrazeneca Ab Quinazoline derivatives
JP4625652B2 (ja) * 2004-05-13 2011-02-02 東ソー株式会社 2−ぺルフルオロアルキルアクリル酸エステルの製造方法
KR20070053237A (ko) * 2004-07-27 2007-05-23 에스지엑스 파마슈티컬스, 인코포레이티드 피롤로-피리딘 키나제 조절제
EP2295419A3 (de) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclinverbindungen
WO2006047671A2 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
JP2008530023A (ja) 2005-02-04 2008-08-07 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の11a,12−誘導体
CA2616224A1 (en) 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
EP3290427A1 (de) * 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazolverbindungen und verfahren zur herstellung und verwendung davon
EP2311814A1 (de) * 2005-12-01 2011-04-20 F. Hoffmann-La Roche AG 2,4,5-Triphenylimidazolinderivate als Inhibitoren der Wechselwirkung zwischen P53 und MDM2-Proteinen zur Verwendung als Antikrebsmittel
IL270446B2 (en) * 2006-12-21 2023-10-01 Paratek Pharm Innc A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
WO2008134048A2 (en) 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds

Also Published As

Publication number Publication date
PT2176216E (pt) 2012-07-27
BRPI0823405A2 (pt) 2012-12-25
BRPI0813990A2 (pt) 2011-09-13
DK2176216T3 (da) 2012-07-30
CN101811980A (zh) 2010-08-25
EP2176216A1 (de) 2010-04-21
EA201070048A1 (ru) 2010-10-29
AU2010200845A1 (en) 2010-04-01
JP2011020996A (ja) 2011-02-03
ZA201008646B (en) 2012-02-29
KR20100042276A (ko) 2010-04-23
US20170283368A1 (en) 2017-10-05
US20090156842A1 (en) 2009-06-18
ZA201000034B (en) 2011-10-26
EP2176216B1 (de) 2012-04-25
WO2009009042A1 (en) 2009-01-15
EA201070233A1 (ru) 2010-08-30
IL204133A0 (en) 2011-07-31
US9522872B2 (en) 2016-12-20
AU2008275701A1 (en) 2009-01-15
CA2693376A1 (en) 2009-01-15
HK1139386A1 (en) 2010-09-17
AU2008275701B2 (en) 2013-04-04
CN101784517A (zh) 2010-07-21
JP2010532759A (ja) 2010-10-14
AU2010200845B2 (en) 2013-01-17
ES2386926T3 (es) 2012-09-06
EP2192111A2 (de) 2010-06-02
EP2192111A3 (de) 2010-10-06
ATE555079T1 (de) 2012-05-15

Similar Documents

Publication Publication Date Title
HRP20120605T1 (hr) Postupci sinteze 9-supstituiranog minociklina
EG24500A (en) A catalyst & progress for the synthesis of C2- oxygenated by the hydrogenation of carbon monoxide
Zhu et al. Enantioselective hydrogenation of (Z)-and (E)-β-arylenamides catalyzed by rhodium complexes of monodentate chiral spiro phosphorous ligands: a new access to chiral β-arylisopropylamines
Hao et al. Air-stable and highly efficient indenyl-derived phosphine ligand: Application to Buchwald–Hartwig amination reactions
Du et al. N-Heterocyclic carbene-catalyzed hydroacylation of isatins with aldehydes: access to 3-acyloxy-1, 3-dihydro-2H-indol-2-ones
Kang et al. Catalytic enantioselective conjugate addition of aromatic amines to fumarate derivatives: asymmetric synthesis of aspartic acid derivatives
Aydemir et al. Synthesis and characterization of tris {2-(N, N-bis (diphenylphosphino) aminoethyl} amine derivatives: Application of a palladium (II) complex as a pre-catalyst in the Heck and Suzuki cross-coupling reactions
Holton et al. Regiocontrolled aromatic palladation
Aydemir et al. Synthesis and characterizations of N, N′‐bis (diphenylphosphino)‐2‐(aminomethyl) aniline derivatives: application of a palladium (II) complex as pre‐catalyst in Heck and Suzuki cross‐coupling reactions
Pereira et al. Binol derivative ligand immobilized onto silica: Alkyl-cyanohydrin synthesis via sequential hydroformylation/heterogeneous cyanosilylation reactions
IL207020A (en) The process for preparing biphenylanilides is converted
CN114989031A (zh) 一种二氧化碳和炔烃合成不饱和酰胺的制备方法
CN113563231B (zh) 一种对位c-h烷基化芳胺及其制备方法
ES2784717T3 (es) Complejos a base de rutenio
Dupau et al. Synthesis of optically active 2-aminotetraline derivatives via enantioselective ruthenium-catalyzed hydrogenation of ene carbamates
ATE520647T1 (de) Verfahren zur herstellung eines primären amins mit tertiärem alpha-c-atom durch umsetzung eines tertiären alkohols mit ammoniak
KR20090055390A (ko) 설파이드 화합물 및 유기 황-인듐 착물을 이용한설파이드화합물 제조방법
CN106478717A (zh) 含三齿nnp配体的稀土金属受阻路易斯酸碱对的合成及其应用
CN103408450A (zh) 一种苊并咪唑氮杂环卡宾烯丙基氯化钯化合物催化合成他米巴罗汀的方法
Qu et al. Chelation controlled reductive amination of cyclic ketones to trans-4-methoxycyclohexylamines: 9-BBN reduction mediated with FeCl3
Hirata et al. Chiral bifunctional organocatalysts bearing a 1, 3-propanediamine unit for the aza-MBH reaction
CN110642737A (zh) 一种酰胺取代的(e,e)-构型枝型共轭二烯衍生物及其制备方法
Ueda et al. Synthesis of allylamides from allyl halides, carbon monoxide, and titanium–nitrogen complexes prepared from molecular nitrogen
CN115304441B (zh) 一种二氧化碳和烯烃合成酰胺的制备方法
CN113735730B (zh) 一种酰基伯胺的制备方法